News Releases

Moffitt Researchers Discover New Therapeutic Target for Non-Small Cell Lung Cancer

Disrupting Jagged2 signaling reprograms immune cells to fight tumors

Moffitt Treats First Clinical Trial Patient with Gamma Delta CAR T for Bone Metastatic Prostate Cancer

The single-center, phase 1 dose-escalation trial targets the prostate stem cell antigen highly expressed in this disease

Registration Open for 2024 Miles for Moffitt Presented by AutoNation

Moffitt Cancer Center aims to raise $1.7 million for innovative cancer research

Moffitt Cancer Center to Revolutionize Cancer Care Delivery Using AI and Machine Learning with NVIDIA, Oracle and Deloitte

Collaboration aims to develop natural language processing models that can streamline clinical workflows, improve documentation accuracy and enhance...

Moffitt Cancer Center Recognized as a Tampa Bay Times Top Workplace for 13th Time

The cancer center recognizes its team members for the critical role they play in the organization’s success

Ken Jones Appointed to Moffitt Cancer Center’s Institute Board of Directors

He is the designee of Brian Lamb, chair of Florida’s Board of Governors

Moffitt Cancer Center Receives Press Ganey Human Experience Award for Patient Experience

The cancer center has ranked in the top 5% of health care providers delivering patient experience

Moffitt’s Dr. Tiffany Carson Joins Global Cancer Grand Challenges Team to Tackle Cancer Inequities

The SAMBAI team will receive up to $25 million over five years to fund research in prostate, breast and pancreatic cancers

Moffitt Researcher First in Florida to Receive Damon Runyon-Rachleff Innovation Award

The award provides grant funding for innovative research projects that impact cancer prevention and care

CancerX Announces Inaugural Start-Up Accelerator Cohort

16 organizations selected to advance their digital health oncology innovations via public-private partnership support

Moffitt Study Highlights Urgent Need to Address Impact of Extreme Weather Events on Cancer Survivorship

Storms can disrupt cancer care, cause stress and contribute to disparities in health outcomes

Moffitt Plays Pivotal Role in FDA Approval of Tumor-Infiltrating Lymphocyte Therapy for Advanced Melanoma

The first-of-its-kind cellular immunotherapy uses the patient’s immune cells to seek out and kill their cancer

Moffitt Study Finds Neoadjuvant Chemotherapy Significantly Improves Outcomes for Penile Squamous Cell Carcinoma Patients

The largest retrospective cohort analysis to date provides much-needed evidence to help guide therapeutic decisions

Moffitt Develops First Individualized Predictive Model for Multiple Myeloma Treatment

Genomics are used to expand biological classification and improve prognostic decisions

Moffitt Study Suggests Improvements Needed for Patient-Reported Outcome Data in Genitourinary Cancer Clinical Studies

Systematic review shows delays in reporting and lower quality analyses